GW Pharmaceuticals PLC

Industry / private company


Location: Cambridge, United Kingdom (GB) GB

ISNI: 0000000406483509

ROR: https://ror.org/01gtctx88

A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma (2021) Twelves C, Sabel M, Checketts D, Miller S, Tayo B, Jove M, Brazil L, et al. Journal article